Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rigosertib-Activated JNK1/2 Eliminate Tumor Cells through p66Shc Activation. | Biology (Basel) | 2020 | 32429320 | PubTator, text mining | PubMed |
| Paired genetic analysis by next-generation sequencing of lung cancer and associated idiopathic pulmonary fibrosis. | Cancer Sci | 2020 | 32426915 | PubTator, text mining | PubMed |
| Immune-profiling of ZIKV-infected patients identifies a distinct function of plasmacytoid dendritic cells for immune cross-regulation. | Nat Commun | 2020 | 32415086 | PubTator, text mining | PubMed |
| Overcoming Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutated Tumours. | J Oncol | 2020 | 32411231 | PubTator, text mining | PubMed |
| Characterization of the Spatial Organization of Raf Isoforms Interacting with K-Ras4B in the Lipid Membrane. | Langmuir | 2020 | 32390436 | PubTator, text mining | PubMed |
| MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling. | Life Sci Alliance | 2020 | 32381551 | PubTator, text mining | PubMed |
| Frequent KIT mutations in skin lesions of patients with BRAF wild-type Langerhans cell histiocytosis. | Virchows Arch | 2020 | 32372223 | PubTator, text mining | PubMed |
| Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma. | J Med Chem | 2020 | 32369358 | PubTator, text mining | PubMed |
| RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors. | Mol Oncol | 2020 | 32336014 | PubTator, text mining | PubMed |
| miR-103/107 regulates left-right asymmetry in zebrafish by modulating Kupffer's vesicle development and ciliogenesis. | Biochem Biophys Res Commun | 2020 | 32334837 | PubTator, text mining | PubMed |
| The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study. | Endocrine | 2020 | 32333269 | PubTator, text mining | PubMed |
| Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non‑radical resection: A real‑world study. | Oncol Rep | 2020 | 32323774 | PubTator, text mining | PubMed |
| A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells. | Blood Cancer J | 2020 | 32321919 | PubTator, text mining | PubMed |
| BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates. | PLoS One | 2020 | 32315324 | PubTator, text mining | PubMed |
| Identification of a RAS-activating TMEM87A-RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer. | Clin Cancer Res | 2020 | 32312893 | PubTator, text mining | PubMed |
| A reference map of the human binary protein interactome. | Nature | 2020 | 32296183 | PubTator, text mining | PubMed |
| AR-dependent phosphorylation and phospho-proteome targets in prostate cancer. | Endocr Relat Cancer | 2020 | 32276264 | PubTator, text mining | PubMed |
| Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material. | BMC Cancer | 2020 | 32264863 | PubTator, text mining | PubMed |
| RAS, wanted dead or alive: Advances in targeting RAS mutant cancers. | Sci Signal | 2020 | 32209699 | PubTator, text mining | PubMed |
| Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method. | Transl Lung Cancer Res | 2020 | 32206555 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=49